AI’s transformative potential in clinical development relies on the industry's ability to rebuild its fractured data infrastructure.
Leigh Cohen
Advertisement
Articles by Leigh Cohen
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
JP Morgan 2026 Preview: Eli Lilly Seeks Bounce Back
2
AstraZeneca Reaches $2 Billion License Agreement with Jacobio Pharma for Pan-KRAS Inhibitor
3
Alnylam Announces $250 Million Investment in Massachusetts Facility
4
Pharmaceutical Executive Daily: Nine New Additions to TrumpRx
5